We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPO icon
2126
XPO
XPO
$23.2B
-6,686
Closed -$499K
YEXT icon
2127
Yext
YEXT
$637M
-82,929
Closed -$525K
YOU icon
2128
Clear Secure
YOU
$4.46B
-90,283
Closed -$1.72M
Z icon
2129
Zillow
Z
$8.07B
-47,584
Closed -$2.2M
GTM
2130
ZoomInfo Technologies
GTM
$1.16B
-107,827
Closed -$1.77M
ZION icon
2131
Zions Bancorporation
ZION
$9.95B
-203,585
Closed -$7.1M
ZLAB icon
2132
Zai Lab
ZLAB
$2.92B
-144,838
Closed -$3.52M
ZM icon
2133
Zoom
ZM
$31.5B
-18,903
Closed -$1.32M
ZS icon
2134
Zscaler
ZS
$29.4B
-67,477
Closed -$10.5M
ZTS icon
2135
Zoetis
ZTS
$32.1B
-4,300
Closed -$748K
TBRG
2136
DELISTED
TruBridge
TBRG
-27,175
Closed -$433K
CNR
2137
Core Natural Resources Inc
CNR
$4.72B
-19,214
Closed -$2.02M
BWIN
2138
Baldwin Insurance Group
BWIN
$3.09B
-16,197
Closed -$376K
CMBT
2139
CMB.TECH NV
CMBT
$5.24B
-802,554
Closed -$13.2M
TXNM
2140
TXNM Energy Inc
TXNM
$5.9B
-26,812
Closed -$1.2M
NBIS
2141
Nebius Group N.V.
NBIS
$59.6B
$0 ﹤0.01%
51,312
-1,221
-2%
EXE
2142
Expand Energy Corp
EXE
$22.2B
-43,606
Closed -$3.76M
OKUR
2143
OnKure Therapeutics
OKUR
$160M
-37,898
Closed -$2.89M
PRSU
2144
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
-13,825
Closed -$362K
KLRS
2145
Kalaris Therapeutics
KLRS
$98.8M
-5,005
Closed -$247K
WHWK
2146
Whitehawk Therapeutics
WHWK
$270M
-307,759
Closed -$1.49M
TPC
2147
Tutor Perini Cor
TPC
$4.8B
-18,732
Closed -$147K
ATSG
2148
DELISTED
Air Transport Services Group
ATSG
-38,433
Closed -$802K
EDR
2149
DELISTED
Endeavor Group Holdings, Inc.
EDR
-20,725
Closed -$412K
CUTR
2150
DELISTED
Cutera, Inc.
CUTR
-249,969
Closed -$1.5M

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.